Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Novel multimethod approach for the determination of the colloidal stability of nanomaterials in complex environmental mixtures using a global stability index: TiO2 as case study.
Badetti E, Brunelli A, Basei G, Gallego-Urrea JA, Stoll S, Walch H, Praetorius A, von der Kammer F, Marcomini A. Badetti E, et al. Among authors: walch h. Sci Total Environ. 2021 Dec 20;801:149607. doi: 10.1016/j.scitotenv.2021.149607. Epub 2021 Aug 17. Sci Total Environ. 2021. PMID: 34425449
Precision medicine for pancreatic cancer: Characterizing the clinico-genomic landscape and outcomes of KRAS G12C-mutated disease.
Keane F, Chou JF, Walch H, Schoenfeld J, Singhal A, Cowzer D, Harrold E, O'Connor C, Park W, Varghese A, El Dika I, Balogun F, Yu KH, Capanu M, Schultz N, Yaeger R, O'Reilly EM. Keane F, et al. Among authors: walch h. J Natl Cancer Inst. 2024 May 3:djae095. doi: 10.1093/jnci/djae095. Online ahead of print. J Natl Cancer Inst. 2024. PMID: 38702822
Molecular and Clinical Determinants of Acquired Resistance and Treatment Duration for Targeted Therapies in Colorectal Cancer.
Harrold E, Keane F, Walch H, Chou JF, Sinopoli J, Palladino S, Al-Rawi DH, Chadalavada K, Manca P, Chalasani S, Yang J, Cercek A, Shia J, Capanu M, Bakhoum SF, Schultz N, Chatila WK, Yaeger R. Harrold E, et al. Among authors: walch h. Clin Cancer Res. 2024 Mar 19. doi: 10.1158/1078-0432.CCR-23-4005. Online ahead of print. Clin Cancer Res. 2024. PMID: 38502113
Concordance in Oncogenic Alterations Between the Primary Tumor and Advanced Disease: Insights Into the Heterogeneity of Intrahepatic Cholangiocarcinoma.
McIntyre SM, Preston WA, Walch H, Sharib J, Kundra R, Sigel C, Lidsky ME, Allen PJ, Morse MA, Chen W, Cercek A, Harding JJ, Abou-Alfa GK, O'Reilly EM, Park W, Balachandran VP, Drebin J, Soares KC, Wei A, Kingham TP, D'Angelica MI, Iacobuzio-Donahue C, Jarnagin WR. McIntyre SM, et al. Among authors: walch h. JCO Precis Oncol. 2024 Feb;8:e2300534. doi: 10.1200/PO.23.00534. JCO Precis Oncol. 2024. PMID: 38394469
Tumor Volume Growth as Surrogate Endpoint in IDH-mt Glioma-Response.
Bhatia A, Moreno R, Reiner AS, Nandakumar S, Walch HS, Malani R, Panageas KS, Mellinghoff IK, Bale TA, Young RJ. Bhatia A, et al. Among authors: walch hs. Clin Cancer Res. 2024 Feb 1;30(3):639. doi: 10.1158/1078-0432.CCR-23-3603. Clin Cancer Res. 2024. PMID: 38298142 No abstract available.
Neoplasia risk in patients with Lynch syndrome treated with immune checkpoint blockade.
Harrold EC, Foote MB, Rousseau B, Walch H, Kemel Y, Richards AL, Keane F, Cercek A, Yaeger R, Rathkopf D, Segal NH, Patel Z, Maio A, Borio M, O'Reilly EM, Reidy D, Desai A, Janjigian YY, Murciano-Goroff YR, Carlo MI, Latham A, Liu YL, Walsh MF, Ilson D, Rosenberg JE, Markowitz AJ, Weiser MR, Rossi AM, Vanderbilt C, Mandelker D, Bandlamudi C, Offit K, Berger MF, Solit DB, Saltz L, Shia J, Diaz LA Jr, Stadler ZK. Harrold EC, et al. Among authors: walch h. Nat Med. 2023 Oct;29(10):2458-2463. doi: 10.1038/s41591-023-02544-9. Epub 2023 Oct 16. Nat Med. 2023. PMID: 37845474
82 results